Home / Human Menopausal Gonadotrophin / Japan
JP ATC G03GA02 · updated 2 Nov 2026
Human Menopausal Gonadotrophin shortage in Japan
Is there a Human Menopausal Gonadotrophin shortage in Japan?
Yes. As of 2 Nov 2026, 4 Human Menopausal Gonadotrophin products are reported short in Japan, the first since 29 Feb 2024. No return date has been given. Main reason: regulatory or licensing.
Also short in Belgium, Czechia, Norway, Sweden. All countries.
Affected products in Japan
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | HMG注射用150IU「フェリング」 | フェリング・ファーマ | 29 Feb 2024 | not given | Regulatory or licensing Regulatory action |
| JP | HMG注射用75IU「フェリング」 | フェリング・ファーマ | 29 Feb 2024 | not given | Regulatory or licensing Regulatory action |
| JP | HMG注用150単位「あすか」 limited | あすか製薬 | 3 Aug 2026 | not given | Manufacturing problem |
| JP | HMG注射用150単位「F」 limited | Fuji Pharma | 6 Aug 2026 | not given | Increased demand |
Source
MHLW (Ministry of Health, Labour and Welfare), supply status of prescription medicines. Official list. Prescription products under limited shipment or supply suspension (delistings excluded); one row per product.